SCHEMBL1100709

SCHEMBL1100709

COC(=O)c1ccc(S(=O)(=O)N(CCCC(F)(F)F)c2sc3cc(F)ccc3c2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
TRPM8 Q7Z2W7 6/20 0.45
L3MBTL1 Q9Y468 1/20 0.41
RORC P51449 3/20 0.40
CMA1 P23946 1/20 0.37
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
TNF P01375 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
NR2F2 P24468 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099990 0.90 TRPM8 (0.53) TRPM8MMP2MMP9MMP8MMP12
SCHEMBL1099706 0.88 TRPM8 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1099583 0.86 TRPM8 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1098942 0.83 TRPM8 (0.59) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1099326 0.80 TRPM8 (0.51) TRPM8L3MBTL1SMN1; SMN2ESR1RAB9A
SCHEMBL1100015 0.79 L3MBTL1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1099626 0.78 TRPM8 (0.55) TRPM8RORCMAPTESR1ESR2
SCHEMBL1098966 0.78 TRPM8 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1099379 0.78 TRPM8 (0.65) TRPM8
SCHEMBL1098589 0.77 L3MBTL1 (0.61) TRPM8L3MBTL1RORCCMA1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 PSEN1 1735/4885PSEN2 1533/4885APH1B 2746/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 PSEN1 1735/4885PSEN2 1533/4885APH1B 2746/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 PSEN1 1735/4885PSEN2 1533/4885APH1B 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.